191 related articles for article (PubMed ID: 17689555)
1. Cellular co-localization of intron-4 containing mRNA and HLA-G soluble protein in melanoma analyzed by fluorescence in situ hybridization.
Sangrouber D; Marcou C; Le Discorde M; Chang CC; Carosella ED; Moreau P
J Immunol Methods; 2007 Sep; 326(1-2):54-62. PubMed ID: 17689555
[TBL] [Abstract][Full Text] [Related]
2. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.
Fujii T; Ishitani A; Geraghty DE
J Immunol; 1994 Dec; 153(12):5516-24. PubMed ID: 7989753
[TBL] [Abstract][Full Text] [Related]
3. The soluble pool of HLA-G produced by human trophoblasts does not include detectable levels of the intron 4-containing HLA-G5 and HLA-G6 isoforms.
Blaschitz A; Juch H; Volz A; Hutter H; Daxboeck C; Desoye G; Dohr G
Mol Hum Reprod; 2005 Oct; 11(10):699-710. PubMed ID: 16330474
[TBL] [Abstract][Full Text] [Related]
4. Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell.
Lesport E; Baudhuin J; LeMaoult J; Sousa S; Doliger C; Carosella ED; Favier B
Hum Immunol; 2009 Dec; 70(12):1000-5. PubMed ID: 19654030
[TBL] [Abstract][Full Text] [Related]
5. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells.
Paul P; Cabestre FA; Ibrahim EC; Lefebvre S; Khalil-Daher I; Vazeux G; Quiles RM; Bermond F; Dausset J; Carosella ED
Hum Immunol; 2000 Nov; 61(11):1138-49. PubMed ID: 11137219
[TBL] [Abstract][Full Text] [Related]
6. Uveal melanoma: no expression of HLA-G.
Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
[TBL] [Abstract][Full Text] [Related]
7. Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers.
Zidi I; Guillard C; Marcou C; Krawice-Radanne I; Sangrouber D; Rouas-Freiss N; Carosella ED; Moreau P
Cell Mol Life Sci; 2006 Nov; 63(22):2669-81. PubMed ID: 17072500
[TBL] [Abstract][Full Text] [Related]
8. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
[TBL] [Abstract][Full Text] [Related]
9. HLA-G expression in malignant melanoma.
Rebmann V; Wagner S; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies.
Paul P; Cabestré FA; Le Gal FA; Khalil-Daher I; Le Danff C; Schmid M; Mercier S; Avril MF; Dausset J; Guillet JG; Carosella ED
Cancer Res; 1999 Apr; 59(8):1954-60. PubMed ID: 10213506
[TBL] [Abstract][Full Text] [Related]
11. Expression and regulation of non-classical HLA-G in renal cell carcinoma.
Dunker K; Schlaf G; Bukur J; Altermann WW; Handke D; Seliger B
Tissue Antigens; 2008 Aug; 72(2):137-48. PubMed ID: 18721274
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HLA-G production in JEG-3 choriocarcinoma cells by RNA interference.
Wengenmayer T; Poehlmann TG; Markert UR
Am J Reprod Immunol; 2004 Mar; 51(3):189-91. PubMed ID: 15209386
[TBL] [Abstract][Full Text] [Related]
13. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma.
Yang Y; Chu W; Geraghty DE; Hunt JS
J Immunol; 1996 Jun; 156(11):4224-31. PubMed ID: 8666791
[TBL] [Abstract][Full Text] [Related]
14. Does 'soluble' HLA-G really exist? Another twist to the tale.
Sargent IL
Mol Hum Reprod; 2005 Oct; 11(10):695-8. PubMed ID: 16330473
[TBL] [Abstract][Full Text] [Related]
15. Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.
Sensi M; Pietra G; Molla A; Nicolini G; Vegetti C; Bersani I; Millo E; Weiss E; Moretta L; Mingari MC; Anichini A
Int Immunol; 2009 Mar; 21(3):257-68. PubMed ID: 19181932
[TBL] [Abstract][Full Text] [Related]
16. Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition.
Yan WH; Fan LA
Cell Res; 2005 Mar; 15(3):176-82. PubMed ID: 15780179
[TBL] [Abstract][Full Text] [Related]
17. HLA-G*0105N null allele encodes functional HLA-G isoforms.
Le Discorde M; Le Danff C; Moreau P; Rouas-Freiss N; Carosella ED
Biol Reprod; 2005 Aug; 73(2):280-8. PubMed ID: 15814900
[TBL] [Abstract][Full Text] [Related]
18. Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules.
Le Friec G; Gros F; Sebti Y; Guilloux V; Pangault C; Fauchet R; Amiot L
J Leukoc Biol; 2004 Dec; 76(6):1125-33. PubMed ID: 15331623
[TBL] [Abstract][Full Text] [Related]
19. Ocular surface epithelial cells up-regulate HLA-G when expanded in vitro on amniotic membrane substrates.
Higa K; Shimmura S; Shimazaki J; Tsubota K
Cornea; 2006 Jul; 25(6):715-21. PubMed ID: 17077667
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of human leukocyte antigen-G (HLA-G) messenger RNAs and proteins in normal human prostate and prostatic adenocarcinoma.
Langat DK; Sue Platt J; Tawfik O; Fazleabas AT; Hunt JS
J Reprod Immunol; 2006 Aug; 71(1):75-86. PubMed ID: 16616377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
